Citi Pharma Ltd. (CPHL) Stock Price and Company Financials
Rs. 73.82
Rs. 0.32 (0.43%)
Last updated: 2026-09-28
Annual Financials (Latest Year: 2025)
SalesRs. 13,153,521,000
Total revenue generated from core business operations during the year.
Profit After TaxRs. 892,039,000
Net earnings after all expenses, interest, and taxes – the "bottom line".
Earnings Per Share (EPS)Rs. 3.90
Profit allocated to each share – higher EPS means better profitability per share.
Gross Profit Margin15.34%
Percentage of revenue left after deducting cost of goods sold – shows production efficiency.
Net Profit Margin6.78%
What percentage of revenue becomes actual profit after all expenses – a key profitability measure.
EPS Growth6.85%
Year‑over‑year increase in earnings per share – indicates growing profitability.
Business Description:
Citi Pharma Limited incorporated as a private limited company in Pakistan under the repealed Companies Ordinance, 1984 on October 08, 2012. The principal activity of the company is manufacturing and sale of pharmaceuticals, medical chemicals and botanical products.
Citi Pharma Limited incorporated as a private limited company in Pakistan under the repealed Companies Ordinance, 1984 on October 08, 2012. The principal activity of the company is manufacturing and sale of pharmaceuticals, medical chemicals and botanical products.
*Annual figures from latest financial statement
| Open | Close | Low | High | Volume |
|---|---|---|---|---|
| 73.50 | 73.82 | 73.50 | 74.69 | 229,008 |